[{"address1": "2-11, Shinbashi-cho", "address2": "Kadoma", "city": "Osaka", "zip": "571-8580", "country": "Japan", "phone": "81 6 6900 9100", "fax": "81 6 6908 2138", "website": "https://www.towayakuhin.co.jp", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.", "fullTimeEmployees": 4588, "companyOfficers": [{"maxAge": 1, "name": "Mr. Itsuro  Yoshida", "age": 72, "title": "President & Representative Director", "yearBorn": 1951, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Shigeki  Fujita", "title": "Operating Officer & GM of Human Resource Development Center", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yutaka  Okuda", "title": "Senior OO & Division Manager of R&D Division and Unit Manager of Innovative Tech Research Unit", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Masao  Tanaka", "age": 69, "title": "Director", "yearBorn": 1954, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 24.35, "open": 24.35, "dayLow": 24.35, "dayHigh": 24.35, "regularMarketPreviousClose": 24.35, "regularMarketOpen": 24.35, "regularMarketDayLow": 24.35, "regularMarketDayHigh": 24.35, "exDividendDate": 1727395200, "payoutRatio": 0.0627, "beta": -0.027, "trailingPE": 7.378788, "volume": 185, "regularMarketVolume": 185, "bid": 18.26, "ask": 23.23, "bidSize": 40000, "marketCap": 1198509440, "fiftyTwoWeekLow": 24.35, "fiftyTwoWeekHigh": 24.35, "priceToSalesTrailing12Months": 0.005079463, "fiftyDayAverage": 24.35, "twoHundredDayAverage": 24.35, "trailingAnnualDividendRate": 60.0, "trailingAnnualDividendYield": 2.4640656, "currency": "USD", "enterpriseValue": 179279511552, "profitMargins": 0.0717, "floatShares": 23083755, "sharesOutstanding": 49220100, "heldPercentInsiders": 0.4813, "heldPercentInstitutions": 0.16947001, "bookValue": 3311.49, "priceToBook": 0.0073531857, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.157, "netIncomeToCommon": 16917999616, "trailingEps": 3.3, "enterpriseToRevenue": 0.76, "enterpriseToEbitda": 4.77, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "TWAPF", "underlyingSymbol": "TWAPF", "shortName": "TOWA PHARMACEUTICAL CO", "longName": "Towa Pharmaceutical Co., Ltd.", "firstTradeDateEpochUtc": 1256131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "03b9ecdb-7b8a-3b9f-81b4-deca43d7c50b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 24.35, "recommendationKey": "none", "totalCash": 35036000256, "totalCashPerShare": 711.822, "ebitda": 37583998976, "totalDebt": 213116993536, "quickRatio": 1.332, "currentRatio": 2.935, "totalRevenue": 235951996928, "debtToEquity": 130.753, "revenuePerShare": 4793.816, "returnOnAssets": 0.02842, "returnOnEquity": 0.11022, "operatingCashflow": 10647000064, "earningsGrowth": 0.157, "revenueGrowth": 0.147, "grossMargins": 0.35904, "ebitdaMargins": 0.15929, "operatingMargins": 0.090670004, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]